Skip to content

VMVirtualMachine.com

Virtual Machine News Platform

  • Home
  • About Us
  • Internetworking
  • Networking 101
  • VM Virtual Machine
    • Azure VM
    • Microsoft Hyper-V
    • VirtualBox
    • Virtual Server Security
    • Virtual Machine Downloads
    • Virtual Machine Security
    • VMware Virtual Machine
  • Tech News
    • Citrix
    • Microsoft
    • VMware
  • Contact Us

Tag: chronic

Fight chronic kidney disease with AI
AI News

Fight chronic kidney disease with AI

vm_adminFebruary 22, 2026

By John Werner Publication Date: 2026-02-21 16:12:00 Kidney with biology and healthcare concept, 3D illustration. 3D illustration. getty We hear…

Parenting Through Chronic Illness: My Journey with Cisco by My Side
Cisco

Parenting Through Chronic Illness: My Journey with Cisco by My Side

vm_adminNovember 12, 2025

By Angee Barnett, Publication Date: 2025-11-12 13:00:00 Finding Strength in the Unexpected They say you can’t pour from an empty…

Bluejay Therapeutics Enrolls First Patient in AZURE-2 Global Phase 3 Clinical Trial Evaluating Brelovitug (BJT-778) Compared to Hepcludex® (Bulevirtide) for Chronic Hepatitis D
Microsoft

Bluejay Therapeutics Enrolls First Patient in AZURE-2 Global Phase 3 Clinical Trial Evaluating Brelovitug (BJT-778) Compared to Hepcludex® (Bulevirtide) for Chronic Hepatitis D

vm_adminSeptember 4, 2025

AZURE-2 evaluates the efficacy and safety of brelovitug as a monotherapy compared head-to-head with Hepcludex (bulevirtide) Enrollment in AZURE-1, a global…

North America Wearable AI Market Size, Share & Trends Analysis Report 2024-2025 & 2031: Rising Chronic Illness and Digital Health Initiatives Fuel Adoption
AI News

North America Wearable AI Market Size, Share & Trends Analysis Report 2024-2025 & 2031: Rising Chronic Illness and Digital Health Initiatives Fuel Adoption

vm_adminApril 7, 2025

Dublin, April 07, 2025 (GLOBE NEWSWIRE) — The “North America Wearable AI Market Size, Share & Trends Analysis Report By…

Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
Microsoft

Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D

vm_adminMarch 26, 2025

… Article Source https://www.manilatimes.net/2025/03/26/tmt-newswire/globenewswire/bluejay-therapeutics-announces-first-patient-dosed-in-azure-1-global-pivotal-clinical-trial-evaluating-brelovitug-bjt-778-as-a-monotherapy-treatment-for-chronic-hepatitis-d/2080574

Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth
AI News

Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth

vm_adminMarch 5, 2025

© RareStock – stock.adobe.com Chronic diseases are a leading driver of health care costs, accounting for 90% of the nation’s…

Google Ad-Tech Users Can Target National Security ‘Decision Makers’ and People With Chronic Diseases
Google

Google Ad-Tech Users Can Target National Security ‘Decision Makers’ and People With Chronic Diseases

vm_adminFebruary 20, 2025

A WIRED investigation into the inner workings of Google’s advertising ecosystem reveals that a wealth of sensitive information on Americans…

  • AI
  • AI Chatbot
  • AI Labs
  • AI News
  • AI Podcast
  • Amazon Web Services
  • Azure VM
  • Blockchain
  • Breaking News
  • Broadcom
  • Cisco
  • Citrix
  • Crypto Corner
  • Google
  • Google Illuminate
  • Grok
  • HPE
  • IBM
  • Intel
  • Internetworking
  • Microsoft
  • Microsoft Hyper-V
  • Networking 101
  • Nutanix
  • Nvidia
  • OpenAI
  • Oracle
  • Storm Watch
  • Trading Corner
  • Virtual Machine
  • Virtual Machine Downloads
  • Virtual Machine Security
  • VirtualBox
  • Virtualization News
  • VM Networking
  • VM Virtual Machine
  • VMware
  • VMware Fusion Pro
  • VMware Virtual Machine
  • VMware Workstation Pro
Copyright © 2026 VMVirtualMachine.com | Extensive News by Ascendoor | Powered by WordPress.